Alzheimer's disease

News

Graphical representation of Brainshuttle antibody at the blood-brain barrier

Roche preps phase 3 for 'Brainshuttle' Alzheimer's drug

Buoyed by data from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's drug from its Brainshuttle programme.

News

Surgeon with surgical gloves on holding a brain scan

Lilly to appeal after CHMP rejects Alzheimer's drug Kisunla

The CHMP has advised against EU approval of Eli Lilly's Alzheimer's drug Kisunla, potentially handing an advantage to Eisai/Biogen's rival drug.

News

Lilly adds Alzheimer's to its DTC platform LillyDirect

Eli Lilly's DTC platform LillyDirect has been expanded to include in-person and telehealth services for people in the US living with Alzheimer's.

News

Prof Vanessa Raymont of the University of Oxford

UK sets aside £2m for digitally-enhanced dementia tests

The UK is providing £2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia.

News

End of the line for Cassava's troubled Alzheimer's programme

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end.

News

Randall J. Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of Neurology at WashU Medicine

Gantenerumab 'shows sign of preventing Alzheimer's dementia'

A study has suggested early targeting of amyloid in the brains of people with inherited Alzheimer's can delay symptoms, but not all are convinced.

Roche preps phase 3 for 'Brainshuttle' Alzheimer's drug

Lilly to appeal after CHMP rejects Alzheimer's drug Kisunla

Lilly adds Alzheimer's to its DTC platform LillyDirect

UK sets aside £2m for digitally-enhanced dementia tests

End of the line for Cassava's troubled Alzheimer's programme

Gantenerumab 'shows sign of preventing Alzheimer's dementia'

EMA seeks input on virtual alternative to animal test

Using AI-driven synthetic personas to take your insights fur...

Alzheimer's disease

Editor's Picks